Literature DB >> 26768564

Conducting clinical trials in outbreak settings: Points to consider.

H Clifford Lane1, Hilary D Marston2, Anthony S Fauci2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26768564      PMCID： PMC4767673          DOI： 10.1177/1740774515618198

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  3 in total

1.  What makes clinical research in developing countries ethical? The benchmarks of ethical research.

Authors:  Ezekiel J Emanuel; David Wendler; Jack Killen; Christine Grady
Journal:  J Infect Dis       Date:  2004-02-17       Impact factor: 5.226

2.  Statistical considerations for a trial of Ebola virus disease therapeutics.

Authors:  Michael A Proschan; Lori E Dodd; Dionne Price
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486

3.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962
  3 in total
  20 in total

1.  Establishment of a research pharmacy to support Ebola clinical research in Liberia.

Authors:  Jerome F Pierson; Matthew Carl Kirchoff; Rev Tijli Tyee; Michael J Montello; Julie K Rhie
Journal:  J Am Pharm Assoc (2003)       Date:  2017-06-10

2.  PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia.

Authors:  Fatorma K Bolay; Greg Grandits; H Clifford Lane; Stephen B Kennedy; Melvin P Johnson; Mosoka P Fallah; Barthalomew Wilson; Wissedi S Njoh; Laura A McNay; Lisa E Hensley; Elizabeth S Higgs
Journal:  J Infect Dis       Date:  2019-04-19       Impact factor: 5.226

3.  The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Authors:  Mohamed Samai; Jane F Seward; Susan T Goldstein; Barbara E Mahon; Durodami Radcliffe Lisk; Marc-Alain Widdowson; Mohamed I Jalloh; Stephanie J Schrag; Ayesha Idriss; Rosalind J Carter; Peter Dawson; S A S Kargbo; Bailah Leigh; Mohamed Bawoh; Jennifer Legardy-Williams; Gibrilla Deen; Wendy Carr; Amy Callis; Robert Lindblad; James B W Russell; Carey R Petrie; Augustin E Fombah; Brima Kargbo; Wendi McDonald; Olamide D Jarrett; Robert E Walker; Paul Gargiullo; Donald Bash-Taqi; Laura Gibson; Abu Bakarr Fofanah; Anne Schuchat
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

4.  Considerations for Use of Investigational Drugs in Public Health Emergencies.

Authors:  Matthew Carl Kirchoff; Jerome F Pierson
Journal:  Ther Innov Regul Sci       Date:  2016-01-01       Impact factor: 1.778

Review 5.  Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls.

Authors:  Dietrich Haubenberger; David B Clifford
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

6.  Collaboration of the NIH and PHS Commissioned Corps in the International Ebola Clinical Research Response.

Authors:  Jerome F Pierson; Matthew C Kirchoff; Susan M Orsega; Scott F Giberson; Betsey R Herpin; Travis W Ready; Michelle L Holshue; Grace G Kelly
Journal:  Fed Pract       Date:  2017-08

7.  OBIF: an omics-based interaction framework to reveal molecular drivers of synergy.

Authors:  Jezreel Pantaleón García; Vikram V Kulkarni; Tanner C Reese; Shradha Wali; Saima J Wase; Jiexin Zhang; Ratnakar Singh; Mauricio S Caetano; Humam Kadara; Seyed Javad Moghaddam; Faye M Johnson; Jing Wang; Yongxing Wang; Scott E Evans
Journal:  NAR Genom Bioinform       Date:  2022-04-05

8.  Beating the Odds: Successful Establishment of a Phase II/III Clinical Research Trial in Resource-Poor Liberia during the Largest-Ever Ebola Outbreak.

Authors:  J Doe-Anderson; B Baseler; P Driscoll; M Johnson; J Lysander; L McNay; W S Njoh; M Smolskis; L Wehrlen; J Zuckerman
Journal:  Contemp Clin Trials Commun       Date:  2016-06-24

9.  Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial.

Authors:  Wei Shen Lim; Garry Meakin; Clare Brittain; Thomas Bewick; Lelia Duley
Journal:  Trials       Date:  2017-11-16       Impact factor: 2.279

10.  Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergency.

Authors:  Gregg S Larson; Beth R Baseler; Marie L Hoover; Jerome F Pierson; Jemee K Tegli; Melvin P Johnson; Mark W S Kieh; Laura A McNay; Wissedi Sio Njoh
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.